Medicare, the U.S. health insurance program for people ages 65 and older, will now provide additional coverage for an imaging…
Articles by Marisa Wexler, MS
A research team led by scientists at the Massachusetts Institute of Technology (MIT) has completed the most sweeping analysis yet…
Six months of treatment with bryostatin slowed cognitive decline in adults with moderately severe Alzheimer’s disease, according to new…
Among people with a genetic form of Alzheimer’s disease, those with more formal education tend to be older at…
Enrollment is complete and testing underway in a Phase 1b/2 clinical trial of Vaccinex’s experimental therapy pepinemab, which aims…
Eli Lilly’s anti-amyloid therapy donanemab significantly slowed cognitive decline for most people with early Alzheimer’s disease in the…
On-demand treatment with BXCL501, an orally dissolving film formulation of dexmedetomidine, significantly eased episodes of agitation among Alzheimer’s disease…
In the earliest stages of Alzheimer’s disease, even before cognitive symptoms have become apparent, there are detectable changes…
A blood test that checks for the abnormal activation of star-shaped cells in the brain called astrocytes may be able…
Eisai and Biogen are seeking approval in Canada and the U.K. for lecanemab to treat early…